Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (2)
- (1)
- (2,981)
- (1)
- (23,536)
- (5)
- (1)
- (1)
- (68)
- (542)
- (9,493)
- (23)
- (1)
- (7)
- (2)
- (13)
- (5)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (256)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (1)
- (253)
- (3)
- (26,512)
- (1)
- (1)
- (2)
- (1)
- (32)
- (1)
- (37,971)
- (1,337)
- (2)
- (2)
- (8)
- (43)
- (3)
- (806)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (140)
- (4)
- (1)
- (110)
- (4,345)
- (3)
- (4)
- (6)
- (7)
- (5)
- (1)
- (1,469)
- (1)
- (1)
- (1)
- (14)
- (11,449)
- (50)
- (6)
- (8)
- (31)
- (21)
- (1)
- (45)
- (4)
- (110)
- (1)
- (34)
- (2)
- (3)
- (129)
- (4)
- (148)
- (98)
- (3)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,575)
- (2)
- (1)
- (160)
- (48)
- (2,559)
- (3)
- (1)
- (2)
- (9)
- (27)
- (1)
- (2)
- (21,948)
- (2,939)
- (4)
- (1)
- (2)
- (114)
- (2,860)
- (4)
- (4)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (34,932)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (6)
- (1)
- (1)
- (18,063)
- (6)
- (162)
- (4)
- (1)
- (14)
- (3)
- (1)
- (3)
- (2)
- (17)
- (19)
- (1)
- (3)
- (3)
- (4)
- (39,205)
- (1,835)
- (1)
- (3)
Recombinant
- (296)
- (9)
- (77,247)
- (1)
Form
- (15)
- (1)
- (2)
- (52,354)
- (14,103)
- (245)
- (168)
- (77)
- (3,358)
Species
- (2)
- (1)
- (2)
- (1)
- (90)
- (557)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (29)
- (2)
- (5)
- (9)
- (15)
- (1)
- (29)
- (72)
- (8)
- (27)
- (1)
- (1,377)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (6)
- (7)
- (1)
- (1)
- (38,027)
- (24)
- (22)
- (8)
- (5)
- (2,390)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (45)
- (32)
- (24)
- (1)
- (2)
- (23)
- (445)
- (8)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (42)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,571)
- (1)
- (44)
- (1)
- (3)
Regulatory Status
- (79)
- (65,629)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
841
–
855
of
134,994
results
Gibco™ Mouse IL-15 Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Gibco™ Mouse IL-17F Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-17F |
| Molecular Weight (g/mol) | 30 kDa |
| Gene Symbol | IL17F |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MRKNPKAGVP ALQKAGNCPP LEDNTVRVDI RIFNQNQGIS VPREFQNRSS SPWDYNITRD PHRFPSEIAE AQCRHSGCIN AQGQEDSTMN SVAIQQEILV LRREPQGCSN SFRLEKMLLK VGCTCVKPIV HQAA |
| Expression System | E. coli |
| For Use With (Application) | Control |
| Source | E. coli |
| Name | Mouse IL-17F |
| Accession Number | Q7TNI7 |
| Gene Alias | C87042; CANDF6; cytokine ML-1; IL17F; IL-17F; IL-24; ILN; Interleukin; interleukin 17F; Interleukin17F; interleukin-17F; interleukin-24; ML1; ML-1; mutant IL-17F |
| Gene ID (Entrez) | 257630 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Gibco™ Human IL-22 Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-22 |
| Molecular Weight (g/mol) | 33.6 kDa |
| Gene Symbol | IL22 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MAPISSHCRL DKSNFQQPYI TNRTFMLAKE ASLADNNTDV RLIGEKLFHG VSMSERCYLM KQVLNFTLEE VLFPQSDRFQ PYMQEVVPFL ARLSNRLSTC HIEGDDLHIQ RNVQKLKDTV KKLGESGEIK AIGELDLLFM SLRNACI |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Human IL-22 |
| Accession Number | Q9GZX6 |
| Gene Alias | Cytokine Zcyto18; EGK_03903; il 22; IL-10-related T-cell-derived inducible factor; IL-10-related T-cell-derived-inducible factor; IL-21; IL22; IL-22; Il22a; IL-22a; IL-D110; ILN; ILTIF; IL-TIF; ILTIF alpha; IL-TIF alpha; ILTIFa; Interleukin; interleukin 10-related T cell-derived inducible factor; interleukin 22; Interleukin22; interleukin-22; Interleukin-22a; RGD1561292; TIFa; TIFIL-23; UNQ3099/PRO10096; ZCYTO18 |
| Biological Activity | Assay 1: Determined by its ability to activate STAT following receptor ligand interaction. Assay 2: Measured by its ability to induce IL-10 secretion in COLO 205 (human colon carcinoma cells). The expected ED50 for this effect is 0.7- 1.0 ng/ml |
| Gene ID (Entrez) | 50616 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | >90% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.4 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 103 kDa |
| Common Name | SARS-CoV-2 Spike Protein S1 |
| Activity | Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human ACE2 at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Spike S1, the ED50 of SARS-COV-2 Spike S1 is 6.79 ng/mL. Immobilized Human ACE2 on COOH Chip, can bind SARS-COV-2 Spike S1 with an affinity constant of 90.8 nM as determined in a SPR assay (Nicoya OpenSPR). |
| Endotoxin Concentration | < 0.1 EU/μg |
| Storage Requirements | -20°C or -80°C if preferred |
| Sequence | SARS-CoV-2 Spike Protein S1, amino acids Val11-Arg682 (Accession # YP_009724390.1) with a C-terminal human Fc-tag and His-tag |
| Expression System | HEK293 cells |
| For Use With (Application) | Binding Assay,Control,ELISA Standard,Surface Plasmon Resonance,Western Blot |
| Name | SARS-CoV-2 Spike Protein S1 (aa11-682), hFc-His Tag |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | PBS with no preservative; pH 7.4 |
| Protein Tag | Fc-tag, His-tag |
| Recombinant | Recombinant |
Gibco™ Mouse VEGF-165 Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 39 kDa |
| Gene Symbol | Vegfa |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MAPTTEGEQK SHEVIKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC CNDEALECVP TSESNITMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKHCEPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Mouse VEGF-165 |
| Accession Number | Q00731 |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-5.0 ng/ml |
| Gene ID (Entrez) | 22339 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Gibco™ Human CD40 Ligand (TNFSF5) Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD154 (CD40 Ligand) |
| Molecular Weight (g/mol) | 16.3 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 = 5 - 10 ng/mL; determined by the dose-dependent stimulation of IL-8 production by human PBMCs. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human CD40 Ligand (TNFSF5) |
| Purification Method | Purified |
| Gene Alias | CD154; CD40 antigen ligand; CD40 ligand; CD40 ligand CD154; CD40 ligand, membrane form; CD40 ligand, soluble form; CD40L; CD40-L; Cd40lg; gp39; hCD40L; H-CD-40-L; HIGM1; IGM; IMD3; Ly62; Ly-62; M-CD-40-L; RP23-153G22.3; T-B cell-activating molecule; T-BAM; T-cell antigen Gp39; TNF-related activation protein; TNFSF5; TRAP; tumor necrosis factor (ligand) superfamily member 5; tumor necrosis factor (ligand) superfamily, member 5; tumor necrosis factor ligand superfamily member 5 |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 = 5 - 10 ng/mL; determined by the dose-dependent stimulation of IL-8 production by human PBMCs. |
| Formulation | 10mM sodium phosphate with no preservative |
| Research Category | Immunology, Stem Cell Research, Signal Transduction |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Approved for shipment on Wet or Dry Ice |
| Content And Storage | -20°C |
| Gene Symbol | CD40LG |
| Sequence | Human CD40 ligand recombinant protein contains 149 amino acids |
| Storage Requirements | -20°C |
| Protein Subtype | Other Proteins |
| Accession Number | P29965 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 959 |
| Product Line | Gibco |
Gibco™ Human beta-NGF Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Purity or Quality Grade | >95% |
|---|---|
| Conjugate | Unconjugated |
| Form | Liquid |
| Common Name | Interferon alpha-2a |
| Molecular Weight (g/mol) | 19.2 kDa |
| Gene Symbol | IFNA2 |
| Activity | EC50 ~ 1 U/mL; determined by use of the cytopathic effect inhibition assay described in [Rubinstein, S. et al. (1981). J. Virol. 37, 755-758]; [Familletti, P.C. et al. (1981). Methods in Enzymology, Vol. 78, 387-394]. The units are determined with respect to the international reference standard for human interferon alpha A (Hu-IFN-alpha-A) provided by the National Institutes of Health [see Pestka, S. (1986). Methods in Enzymology, Academic Press, New York 119, 14-23]. Unit of activity measured on bovine MDBK cells with vesicular stomatitis virus (VSV). |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -80°C, Avoid Freeze/Thaw Cycles |
| Concentration | 0.2 mg/mL |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Immunoprecipitation,Western Blot |
| Name | Human IFN-alpha A (alpha 2a) (Carrier-Free) |
| Accession Number | P01563 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | alpha-2a interferon; IFNA; IFNA2; IFNA2A; IFNA2B; IFNA2C; IFN-alpha-2; IFN-alphaA; INFA2; Interferon; interferon alpha 2; interferon alpha 2a; interferon alpha 2b; interferon alpha A; interferon alpha-2; Interferon alpha-A; interferon, alpha 2; leIF A |
| Product Type | Protein |
| Gene ID (Entrez) | 3440 |
| Formulation | PBS with no preservative |
| Recombinant | Recombinant |
Promotions Available
Invitrogen™ PD98059
Invitrogen™ PD98059
PD98059 is a potent and selective cell permeable inhibitor of MAP kinase kinase (MEK). It is provided in a Lyophilized format.
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Invitrogen™ Human CTLA-4 His-tag Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Purity or Quality Grade | >90 % as determined by SDS-PAGE. ≥95 % as determined by SEC-HPLC. |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.4 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 15 kDa |
| Common Name | CTLA-4 (CD152) |
| Gene Symbol | CTLA4 |
| Activity | 1. Immobilized Recombinant Human CD86/B7-2 Protein (Fc Tag) at 2 μg/mL (100 μL/well) can bind Human CTLA-4 His-tag Recombinant Protein, the EC50 is 2.6-8 ng/mL. 2. Measured by its ability to inhibit IL-2 secretion by stimulated Jurkat human acute T cell leukemia cells. The ED50 for this effect is 0.05-0.3 μg/mL when stimulated with 1 μg/mL Recombinant Human B7-1/CD80. 3.Captured Ipilimumab on proA Chip can bind Human CTLA-4 His-tag Recombinant Protein with an affinity constant of 20.03 nM as determined in a SPR assay (Biacore T200)(Routinely tested). 4.Loaded Ipilimumab on ProA Biosensor, can bind Human CTLA-4 His-tag Recombinant Protein with an affinity constant of 5.15 nM as determined in BLI assay (Sartorius Octet Red384) (Routinely tested). |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C or -80°C if preferred |
| Sequence | Human CTLA4, amino acids Met1-Phe162 (Accession # NP_005205.2) with a C-terminal His-tag |
| Expression System | HEK293 cells |
| For Use With (Application) | Binding Assay,Bioactivity,Control |
| Name | Human CTLA-4 His-tag |
| Accession Number | P16410 |
| Purification Method | Purified |
| Gene Alias | ALPS5; CD; CD152; CD152 antigen; CD152 isoform; CD152 protein; CD152 protein precursor; celiac disease 3; CELIAC3; Ctla4; CTLA-4; cytotoxic T lymphocyte associated antigen 4 short spliced form; cytotoxic T-lymphocyte associated protein 4; cytotoxic T-lymphocyte protein 4; cytotoxic T-lymphocyte protein 4 isoform CTLA4-TM; cytotoxic T-lymphocyte-associated antigen 4; cytotoxic T-lymphocyte-associated protein 4; cytotoxic T-lymphocyte-associated serine esterase-4; EGK_04712; GRD4; GSE; ICOS; IDDM12; insulin-dependent diabetes mellitus 12; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4; Ly-56; sCTLA4; soluble form; transmembrane form |
| Product Type | Protein |
| Gene ID (Entrez) | 1493 |
| Formulation | PBS with 0.01% Tween 80, 5% mannitol, 5% trehalose and no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
Gibco™ Human/Mouse/Rat BMP-2 Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | BMP-2 |
| Molecular Weight (g/mol) | 25.8 kDa |
| Gene Symbol | BMP2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | QAKHKQRKRL KSSCKRHPLY VDFSDVGWND WIVAPPGYHA FYCHGECPFP LADHLNSTNH AIVQTLVNSV NSKIPKACCV PTELSAISML YLDENEKVVL KNYQDMVVEG CGCR |
| Expression System | CHO cells |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | CHO cells |
| Name | Human/Mouse/Rat BMP-2 |
| Accession Number | P12643, P21274, P49001 |
| Gene Alias | 2610024H22Rik; AI467020; AL117858; AW546137; BB189135; BDA2; BMP; BMP2; BMP-2; BMP2A; BMP-2A; BMPRII; BMPR-II; Bone morphogenetic; Bone morphogenetic protein; Bone morphogenetic protein 2; bone morphogenetic protein 2 precursor (BMP-2) (BMP-2A); bone morphogenetic protein 2A; H-BMP-2; morphogen |
| Biological Activity | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 40-100 ng/ml |
| Gene ID (Entrez) | 12156, 29373, 650 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Gibco™ Human CCL19 (MIP-3 beta) Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Gibco™ Human CCL22 (MDC) (67 aa) Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | MDC |
| Molecular Weight (g/mol) | 8 kDa |
| Gene Symbol | CCL22 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | YGANMEDSVC CRDYVRYRLP LRVVKHFYWT SDSCPRPGVV LLTFRDKEIC ADPRVPWVKM ILNKLSQ |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human CCL22 (MDC) (67 aa) |
| Accession Number | O00626 |
| Gene Alias | A-152E5.1; Abcd1; ABCD-1; Activated B and dendritic cell-derived; AW060611; CC chemokine ABCD-1; CC chemokine STCP-1; C-C motif chemokine 22; C-C motif chemokine ligand 22; Ccl22; chemokine (C-C motif) ligand 22; DC/B-CK; DCBCK; dendritic cell and B cell derived chemokine; macrophage-derived chemokine; MDC; MDC(1-69); MDC(3-69); MDC(5-69); MDC(7-69); MGC108943; MGC34554; RP24-69A20.1; Scya22; small inducible cytokine A22; SMALL INDUCIBLE CYTOKINE A22 PRECURSOR (CC CHEMOKINE ABCD-1) (ACTIVATED B AND DENDRITIC CELL-DERIVED); small inducible cytokine subfamily A (Cys-Cys) member 22; small inducible cytokine subfamily A (Cys-Cys), member 22; small inducible cytokine subfamily A, member 22; small inducible cytokine subfamily A22; small-inducible cytokine A22; STCP-1; stimulated T cell chemotactic protein 1; stimulated T-cell chemotactic protein 1 |
| Biological Activity | Determined by its ability to chemoattract human T cells using a concentration range of 10.0-100.0 ng/ml |
| Gene ID (Entrez) | 6367 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Gibco™ Human I-309 (CCL1) Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CCL1 |
| Molecular Weight (g/mol) | 8.5 kDa |
| Gene Symbol | CCL1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SKSMQVPFSR CCFSFAEQEI PLRAILCYRN TSSICSNEGL IFKLKRGKEA CALDTVGWVQ RHRKMLRHCP SKRK |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human I-309 (CCL1) |
| Accession Number | P22362 |
| Gene Alias | BF534335; C-C motif chemokine 1; C-C motif chemokine ligand 1; CCL 1; Ccl1; CCR8 ligand; chemokine (C-C motif) ligand 1; I-309; inflammatory cytokine I-309; P500; SCYA1; SISe; SIS-epsilon; small inducible cytokine A1; small inducible cytokine A1 (I-309, homologous to mouse Tca-3); small-inducible cytokine A1; T lymphocyte-secreted protein I-309; TCA3; TCA-3; T-cell activation protein 3 |
| Biological Activity | Determined by its ability to chemoattract human monocytes population using a concentration range of 10.0-30.0 ng/ml |
| Gene ID (Entrez) | 6346 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
Gibco™ Human CCL24 (Eotaxin-2) Recombinant Protein, PeproTech®
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Eotaxin 2 |
| Molecular Weight (g/mol) | 8.8 kDa |
| Gene Symbol | CCL24 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | VVIPSPCCMF FVSKRIPENR VVSYQLSSRS TCLKGGVIFT TKKGQQFCGD PKQEWVQRYM KNLDAKQKKA SPRARAVA |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human CCL24 (Eotaxin-2) |
| Accession Number | O00175 |
| Gene Alias | CC chemokine CCL24; C-C motif chemokine 24; C-C motif chemokine ligand 24; Ccl24; chemokine (C-C motif) ligand 24; Ckb-6; CK-beta-6; Eosinophil chemotactic protein 2; Eotaxin2; eotaxin-2; eotaxin-2-like protein; MPIF2; MPIF-2; Myeloid progenitor inhibitory factor 2; Scya24; small inducible cytokine A24; small inducible cytokine subfamily A (Cys-Cys), member 24; small-inducible cytokine A24 |
| Biological Activity | Determined by its ability to chemoattract using human peripheral blood eosinophils using a concentration of 50.0-100.0 ng/ml |
| Gene ID (Entrez) | 6369 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |